Stocks · Health care · Pharmaceutical Preparations

CORCEPT THERAPEUTICS INC

CORT Clue Score67

United States Fiscal year ends December CIK 0001088856 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

20 insiders · 501 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sean Maduck

See Remarks

—

$62.86M (75) scheduled

−$62.86M

52,938

0.0490%

$4.38M

—

Joseph K Belanoff

Chief Executive Officer

—

$50.86M (38) scheduled

−$50.86M

2,565,489

2.37%

$212.10M

+37.6%

Patrick G Enright

Director

—

$45.33M (30)

−$45.33M

318,885

0.2950%

$26.36M

−96.0%

Joseph Douglas Lyon

See Remarks

—

$32.43M (52) scheduled

−$32.43M

5,683

0.0053%

$469.85K

—

William Guyer

Chief Development Officer

—

$28.44M (41) scheduled

−$28.44M

4,313

0.0040%

$356.58K

—

Atabak Mokari

Chief Financial Officer

—

$18.73M (22) scheduled

−$18.73M

16,304

0.0151%

$1.35M

—

David L Mahoney

Director

—

$17.40M (14) scheduled

−$17.40M

1,133,539

1.05%

$93.72M

+2.5%

G Leonard Baker Jr

Director

$17.01M (32)

$1.77M (4) scheduled

+$15.24M

2,241,893

2.07%

$185.35M

+152.7%

Gary Charles Robb

Chief Business Officer

$54.59K (1)

$14.89M (34)

−$14.84M

114,059

0.1055%

$9.43M

+433.5%

Roberto Wandenkolk Vieira

President, Oncology

—

$8.13M (13) scheduled

−$8.13M

3,946

0.0037%

$326.24K

−3.0%

Longitude Venture Partners L.P. entity

10% owner

—

$7.21M (16)

−$7.21M

10,956,002

10.14%

$905.79M

−25.5%

James N Wilson

Director

—

$6.44M (18) scheduled

−$6.44M

2,529,086

2.34%

$209.09M

−12.3%

Daniel N Swisher JR

Director

—

$3.90M (36) scheduled

−$3.90M

0

0.0000%

$0.00

—

Kimberly Park

Director

—

$3.27M (1) scheduled

−$3.27M

0

0.0000%

$0.00

—

Robert S Fishman

Chief Medical Officer

—

$1.52M (12) scheduled

−$1.52M

0

0.0000%

$0.00

—

Hazel Hunt

Chief Scientific Officer

—

$631.75K (1)

−$631.75K

255,437

0.2363%

$21.12M

+127,619%

Renee D Gala

Director

$155.10K (2)

—

+$155.10K

10,000

0.0093%

$826.76K

—

Bakker Juliet Tammenoms

10% owner

—

—

—

133,539

0.1235%

$11.04M

—

Daniel Bradbury

Director

—

—

—

130,575

0.1208%

$10.80M

−26.6%

Gillian Cannon

Director

—

—

—

0

0.0000%

$0.00

—